Impact of Airline Secondhand Tobacco Smoke Exposure on Respiratory Health and Lung Function Decades After Exposure Cessation

• Published in: Chest Vol. 162; no. 3; pp. 556 - 568
• Main Authors: Diaz del Valle, Fernando, Zakrajsek, Jonathan K., Min, Sung-Joon, Koff, Patricia B., Bell, Harold W., Kincaid, Keegan A., Frank, Daniel N., Ramakrishnan, Vijay, Ghosh, Moumita, Vandivier, R. William
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.09.2022; American College of Chest Physicians
• Subjects: Cohort Studies; COPD; COPD: Original Research; Female; Humans; Lung; Male; occupational lung disease; Pulmonary Disease, Chronic Obstructive - diagnosis; Pulmonary Disease, Chronic Obstructive - epidemiology; Pulmonary Disease, Chronic Obstructive - etiology; Quality of Life; smoking and tobacco; Tobacco Smoke Pollution - adverse effects; women’s health; BD; women’s health; Dlco; occupational lung disease; SGRQ; CAT; VGDF; smoking and tobacco; COPD; RAND-36; SHS
• ISSN: 0012-3692; 1931-3543
• DOI: 10.1016/j.chest.2022.02.049

Twenty-five percent to 45% of COPD is caused by exposures other than active smoking. Secondhand tobacco smoke (SHS) has been suggested as an independent cause of COPD, based on its association with increased respiratory symptoms and a small decrease in lung function, but its impact on respiratory health and lung function after exposure cessation has not been explored. What are the consequences of airline SHS exposure on respiratory health and lung function decades after cessation? We performed a cohort study involving flight attendants because of their exposure to SHS that stopped > 20 years ago. We included subjects ≥ 50 years of age with > 1 year vs ≤ 1 year of airline SHS exposure (ie, exposed vs unexposed). Respiratory quality of life, as determined by the St. George’s Respiratory Questionnaire (SGRQ), was the primary outcome for respiratory health. Key secondary outcomes included general quality of life (the Rand Corporation modification of the 36-item Short Form Health Survey Questionnaire; RAND-36), respiratory symptoms (COPD Assessment Test; CAT), and spirometry. The study enrolled 183 SHS-exposed and 59 unexposed subjects. Exposed subjects were 66.7 years of age, and 90.7% were female. They were hired at 23.8 years of age, were exposed to airline SHS for 16.1 years, and stopped exposure 27.5 years before enrollment. Prior SHS exposure was associated with worsened SGRQ (6.7 units; 95% CI, 2.7-10.7; P = .001), RAND-36 physical and social function, and CAT vs unexposed subjects. SHS exposure did not affect prebronchodilator spirometry or obstruction, but was associated with lower postbronchodilator FEV1 and FEV1/FVC, total lung capacity, and diffusing capacity of the lungs for carbon monoxide in a subset of subjects. Former smoking and SHS exposure synergistically worsened SGRQ (β = 8.4; 95% CI, 0.4-16.4; P = .04). SHS exposure in people who never smoked replicated primary results and was associated with worsened SGRQ vs unexposed people (4.7 units; 95% CI, 0.7-7.0; P = .006). Almost three decades after exposure ended, airline SHS exposure is strongly and dose-dependently associated with worsened respiratory health, but less robustly associated with airflow abnormalities used to diagnose COPD.